Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size
Open Access
- 5 February 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 2442
Abstract
Inhibition of succinate dehydrogenase (SDH) with malonate during reperfusion reduces infarct size in isolated mice hearts submitted to global ischemia. However, malonate has toxic effects that preclude its systemic administration in animals. Here we investigated the effect of intracoronary malonate on infarct size in pigs submitted to transient coronary occlusion. Under baseline conditions, 50 mmol/L of intracoronary disodium malonate, but not lower concentrations, transiently reduced systolic segment shortening in the region perfused by the left anterior descending coronary artery (LAD) in open-chest pigs. To assess the effects of SDH inhibition on reperfusion injury, saline or malonate 10 mmol/L were selectively infused into the area at risk in 38 animals submitted to ischemia-reperfusion. Malonate improved systolic shortening in the area at risk two hours after 15 min of ischemia (0.18 ± 0.07 vs 0.00 ± 0.01 a.u., p = 0.025, n = 3). In animals submitted to 40 min of ischemia, malonate reduced reactive oxygen species production (MitoSOX staining) during initial reperfusion and limited infarct size (36.46 ± 5.35 vs 59.62 ± 4.00%, p = 0.002, n = 11), without modifying reperfusion arrhythmias. In conclusion, inhibition of SDH with intracoronary malonate during early reperfusion limits reperfusion injury and infarct size in pigs submitted to transient coronary occlusion without modifying reperfusion arrhythmias or contractile function in distant myocardium.Keywords
This publication has 38 references indexed in Scilit:
- Mitochondria as a target of cardioprotection in models of preconditioningJournal of Bioenergetics and Biomembranes, 2017
- Succinate metabolism: a new therapeutic target for myocardial reperfusion injuryCardiovascular Research, 2016
- Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trialsInternational Journal of Cardiology, 2016
- Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning2015
- Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigsCardiovascular Research, 2015
- The mitochondrial permeability transition: A current perspective on its identity and role in ischaemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 2015
- Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: A randomized controlled clinical trialInternational Journal of Cardiology, 2014
- Transient complex I inhibition at the onset of reperfusion by extracellular acidification decreases cardiac injuryAmerican Journal of Physiology-Cell Physiology, 2014
- Malonate Metabolism: Biochemistry, Molecular Biology, Physiology, and Industrial ApplicationBMB Reports, 2002
- Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.Circulation Research, 1988